News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
837,806 Results
Type
Article (71110)
Company Profile (357)
Press Release (766319)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (229177)
Career Advice (3489)
Deals (39291)
Drug Delivery (152)
Drug Development (89578)
Employer Resources (196)
FDA (18056)
Job Trends (16953)
News (389004)
Policy (38066)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2974)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (165)
Alliances (55945)
ALS (192)
Alzheimer's disease (1813)
Antibody-drug conjugate (ADC) (373)
Approvals (18268)
Artificial intelligence (634)
Autoimmune disease (202)
Automation (48)
Bankruptcy (399)
Best Places to Work (12500)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (211)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (697)
Cancer (5338)
Cardiovascular disease (474)
Career advice (2986)
Career pathing (44)
CAR-T (315)
CDC (68)
Celiac Disease (2)
Cell therapy (837)
Cervical cancer (41)
Clinical research (76088)
Collaboration (1957)
Company closure (6)
Compensation (1234)
Complete response letters (82)
COVID-19 (2971)
CRISPR (110)
C-suite (980)
Cystic fibrosis (157)
Data (6750)
Decentralized trials (2)
Denatured (56)
Depression (163)
Diabetes (546)
Diagnostics (7253)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (303)
Drug pricing (228)
Drug shortages (35)
Duchenne muscular dystrophy (265)
Earnings (98891)
Editorial (68)
Employer branding (22)
Employer resources (167)
Events (133825)
Executive appointments (1075)
FDA (21443)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1637)
Gene editing (231)
Generative AI (56)
Gene therapy (707)
GLP-1 (1152)
Government (5408)
Grass and pollen (8)
Guidances (389)
Healthcare (20747)
HIV (72)
Huntington's disease (55)
IgA nephropathy (90)
Immunology and inflammation (305)
Immuno-oncology (75)
Indications (137)
Infectious disease (3289)
Inflammatory bowel disease (219)
Inflation Reduction Act (16)
Influenza (133)
Intellectual property (269)
Interviews (650)
IPO (17811)
IRA (60)
Job creations (4794)
Job search strategy (2434)
JPM (72)
Kidney cancer (20)
Labor market (97)
Layoffs (654)
Leadership (44)
Legal (9615)
Liver cancer (101)
Longevity (21)
Lung cancer (714)
Lymphoma (395)
Machine learning (48)
Management (66)
Manufacturing (916)
MASH (182)
Medical device (14939)
Medtech (15007)
Mergers & acquisitions (22617)
Metabolic disorders (1469)
mRNA (196)
Multiple sclerosis (180)
NASH (22)
Neurodegenerative disease (384)
Neuropsychiatric disorders (109)
Neuroscience (3238)
Neurotech (1)
NextGen: Class of 2026 (7397)
Non-profit (5049)
Now hiring (70)
Obesity (723)
Opinion (348)
Ovarian cancer (177)
Pain (235)
Pancreatic cancer (256)
Parkinson's disease (317)
Partnered (36)
Patents (550)
Patient recruitment (564)
Peanut (65)
People (66527)
Pharmaceutical (93)
Pharmacy benefit managers (34)
Phase 1 (23619)
Phase 2 (33196)
Phase 3 (24913)
Pipeline (6291)
Policy (353)
Postmarket research (3156)
Preclinical (10378)
Press Release (72)
Prostate cancer (273)
Psychedelics (59)
Radiopharmaceuticals (317)
Rare diseases (1022)
Real estate (7176)
Recruiting (76)
Regulatory (28073)
Reports (61)
Research institute (2704)
Resumes & cover letters (552)
Rett syndrome (31)
RNA editing (20)
RSV (90)
Schizophrenia (164)
Series A (277)
Series B (205)
Service/supplier (14)
Sickle cell disease (109)
Special edition (29)
Spinal muscular atrophy (174)
Sponsored (49)
Startups (4166)
State (2)
Stomach cancer (20)
Supply chain (118)
Tariffs (100)
The Weekly (114)
Vaccines (1176)
Venture capital (102)
Weight loss (487)
Women's health (105)
Worklife (23)
Date
Today (153)
Last 7 days (741)
Last 30 days (3096)
Last 365 days (32029)
2026 (6122)
2025 (32210)
2024 (37288)
2023 (42265)
2022 (53639)
2021 (58395)
2020 (57391)
2019 (50976)
2018 (38763)
2017 (35932)
2016 (36733)
2015 (44284)
2014 (39635)
2013 (35500)
2012 (36160)
2011 (36183)
2010 (35635)
Location
Africa (1126)
Alabama (92)
Alaska (7)
Arizona (350)
Arkansas (15)
Asia (49058)
Australia (8300)
California (12159)
Canada (3482)
China (1237)
Colorado (511)
Connecticut (533)
Delaware (361)
Europe (111540)
Florida (1813)
Georgia (394)
Hawaii (3)
Idaho (68)
Illinois (997)
India (79)
Indiana (573)
Iowa (23)
Japan (471)
Kansas (134)
Kentucky (46)
Louisiana (35)
Maine (85)
Maryland (1505)
Massachusetts (8871)
Michigan (361)
Minnesota (685)
Mississippi (7)
Missouri (145)
Montana (37)
Nebraska (30)
Nevada (135)
New Hampshire (87)
New Jersey (3273)
New Mexico (32)
New York (3211)
North Carolina (1626)
North Dakota (10)
Northern California (5938)
Ohio (373)
Oklahoma (23)
Oregon (48)
Pennsylvania (2435)
Puerto Rico (25)
Rhode Island (50)
South America (1510)
South Carolina (71)
South Dakota (1)
Southern California (4765)
Tennessee (195)
Texas (1908)
United States (43622)
Utah (367)
Vermont (1)
Virginia (305)
Washington D.C. (84)
Washington State (992)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
837,806 Results for "locus pharmaceuticals inc out of business".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
Biopharma companies—including AstraZeneca, BioNTech and Agios—peered farther into the future on the second day of JPM, setting both revenue and R&D targets through the end of the decade.
January 14, 2026
·
4 min read
·
Tristan Manalac
Policy
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
In his annual letter, Flagship Pioneering’s Noubar Afeyan lays out a choice between near-term “human-made miracles” and a reversion to the pain and suffering of past diseases due to “growing contempt” in the U.S. for the scientific method.
January 12, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria
January 8, 2026
·
3 min read
Press Releases
Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections
October 29, 2025
·
2 min read
Drug pricing
Before GLP-1s, a Great Pricing Battle Played Out in Hep C Market
The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C. A similar dynamic is now playing out between Eli Lilly and Novo Nordisk in the obesity space, with some key differences.
November 18, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
January 9, 2026
·
8 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
December 24, 2025
·
12 min read
Press Releases
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 12, 2026
·
3 min read
Press Releases
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
January 13, 2026
·
7 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2025 Results and Provides Business Update
November 13, 2025
·
11 min read
1 of 83,781
Next
